PHE data shows vaccines reduce severe COVID-19 in older adults
Public Health England (PHE) has submitted a pre-print of a real-world study, with data showing that both the Pfizer and Oxford/AstraZeneca vaccines are highly...
New transatlantic cancer research partnership
The two largest funders of cancer research in the world are set to make radical progress against cancer with a new scientific cancer research...
How pharma can enhance its digital presence
With COVID-19 accelerating online migration this year, the pharma industry has had to embrace online - and fast. Traditionally reliant on face-to-face communication and...
Finding a job and recruiting in 2021
PharmaJobs understands the pressure on finding a job and recruiting so it’s making some changes to help recruiters and job seekers in 2021. As we...
Career advice from pharma professionals
In an industry which has excelled in the face of adversity this year, some expert advice can help you do the same in your...
Changes to the landscape of commercial recruitment
As Covid-19 continues to shift and shape the landscape of commercial recruitment, Pf talks with Andy Anderson at Evolve about its impact going forward. How...
Why candidates need to be omnichannel ready
Judy Phillips from Chase looks at how working practices are changing and why it is important that candidates in 2020 are omnichannel ready. COVID-19 and...
Interview with Pf Awards Future Leader winner
In this interview, Pf Awards Future Leader winner, Lauren Laskier, reflects on her accolade and how the recognition has pushed her forward in her...
Reducing time to market for new COVID-19 vaccines
With the target set to offer a COVID-19 vaccine to a further 17.7 million people in the next five priority groups - including all...
Bringing in change with Brexit
With a post-Brexit deal agreed, it is time to weigh up the opportunities and the risks for industry. From clinical trials to marketing authorisation,...
